Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21561439 | 0.93 | TSHR (0.39) | MEN1KMT2ACYP3A4LPAR3TSHR | |
| SCHEMBL11316382 | 0.89 | MEN1 (0.32) | MEN1KMT2ACYP3A4TSHR | |
| SCHEMBL777116 | 0.86 | CYP3A4 (0.56) | CYP3A4LPAR3TSHRLPAR1LPAR2 | |
| SCHEMBL776765 | 0.84 | LPAR3 (0.52) | CYP3A4LPAR3TSHRLPAR1LPAR2 | |
| SCHEMBL24966972 | 0.82 | LPAR3 (0.55) | CYP3A4LPAR3TSHRLPAR1LPAR2 | |
| SCHEMBL23497133 | 0.82 | CYP3A4 (0.52) | CYP3A4LPAR3TSHRLPAR1LPAR2 | |
| SCHEMBL24966035 | 0.82 | LPAR3 (0.55) | CYP3A4LPAR3TSHRLPAR1LPAR2 | |
| SCHEMBL24966022 | 0.82 | LPAR3 (0.55) | CYP3A4LPAR3TSHRLPAR1LPAR2 | |
| SCHEMBL23497169 | 0.82 | CYP3A4 (0.52) | CYP3A4LPAR3TSHRLPAR1LPAR2 | |
| SCHEMBL23497156 | 0.82 | LPAR3 (0.55) | CYP3A4LPAR3TSHRLPAR1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119735745-A | Phosphorus modified styrene-butadiene rubber polymer and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119591768-A | Organic polymer carrier, Z-N catalyst, and preparation method and application thereof | 中国石油天然气股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| US-20240383930-A1 | METHOD FOR PRODUCING VINYLPHOSPHONIC ACID MONOESTER | UNIVERSITY OF FUKUI (JP) | 2024-11-21 | — | — | US | claimed |
| EP-4410800-A1 | METHOD FOR PRODUCING VINYLPHOSPHONIC ACID MONOESTER | University of Fukui (JP) | 2024-08-07 | — | — | EP | claimed |
| CN-117980313-A | Method for producing vinyl phosphonic acid monoester | 国立大学法人福井大学 | 2024-05-03 | — | — | CN | claimed |
| WO-2023054663-A1 | METHOD FOR PRODUCING VINYLPHOSPHONIC ACID MONOESTER | 国立大学法人福井大学 | 2023-04-06 | — | — | WO | claimed |
| CN-114181250-A | Alkenyl phosphine compound and preparation method thereof | 中国石油化工股份有限公司 | 2022-03-15 | — | — | CN | claimed |
| US-20220045389-A1 | ELECTROLYTE FOR LITHIUM AIR BATTERIES, AND LITHIUM AIR BATTERY USING THE SAME | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2022-02-10 | — | — | US | claimed |
| CN-113169395-A | Electrolyte for lithium-air battery and lithium-air battery using same | 国立研究开发法人物质·材料研究机构 | 2021-07-23 | — | — | CN | claimed |
| CN-1288791-C | Lithium secondary battery and a method for preparing the same | SAMSUNG SDI CO LTD (KR) | 2006-12-06 | — | — | CN | claimed |
| CN-1501542-A | Lithium secondary battery and a method for preparing the same | 三星SDI株式会社 | 2004-06-02 | — | — | CN | claimed |
| EP-3901181-B1 | METHOD FOR PRODUCING POLYVINYLPHOSPHONIC ACID COPOLYMER | MARUZEN PETROCHEM CO LTD (JP) | 2026-02-18 | — | — | EP | disclosed |
| EP-4682205-A1 | CURED PRODUCT, CURED PRODUCT-CONTAINING CARBON MATERIAL, NEGATIVE ELECTRODE, AND NONAQUEOUS SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-20260011730-A1 | CURED PRODUCT, CURED PRODUCT-CONTAINING CARBON MATERIAL, NEGATIVE ELECTRODE, AND NONAQUEOUS SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-01-08 | — | — | US | disclosed |
| US-12319766-B2 | Core-shell-type polymer fine particles having phosphonic acid or phosphonic acid ester structure, particle dispersion, molded article, and method for producing said fine particles | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2025-06-03 | — | — | US | disclosed |
| WO-1997049736-A2 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
| EP-0132630-A2 | Polymers containing phosphonic acid groups, their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1985-02-13 | — | — | EP | disclosed |
| US-4246103-A | INHIBIT PRECIPITATION OF HARD WATER IONS ESPECIALLY FOR INDUSTRIAL WATER AND SLUDGE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-01-20 | — | — | US | disclosed |
| US-4017564-A | NICKEL OR COBALT CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1977-04-12 | — | — | US | disclosed |
| US-3962201-A | PROCESS FOR POLYMERIZING ACRYLICS EMPLOYING (HYDROCARBON-PEROXY HYDROCARBON) PHOSPHONATES | S. A. TEXACO BELGIUM N.V. (BE) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240383930-A1 | METHOD FOR PRODUCING VINYLPHOSPHONIC ACID MONOESTER | PHOSPHO1, MVD, PPIP5K2 | MEN1 153/4885KMT2A 1969/4885CYP3A4 483/4885 |
| US-20260011730-A1 | CURED PRODUCT, CURED PRODUCT-CONTAINING CARBON MATERIAL, NEGATIVE ELECTRODE, AND NONAQUEOUS SECONDARY BATTERY | DNMT3A, TET3, SMCHD1 | MEN1 479/4885KMT2A 364/4885CYP3A4 3015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.